Story perspectives
Trump Considers Legal Action Against Hims Over Wegovy Sales
2/14/2026
1 of 1
Story summary
- U.S. President Donald Trump may initiate legal action against Hims for attempting to sell a compounded version of Novo Nordisk's Wegovy.
- The FDA indicated potential enforcement actions and referred Hims to the Department of Justice for possible violations of the Food, Drug, and Cosmetic Act.
- Compounded drugs are only legal under specific conditions.
- Hims claims its products are legal because they are personalized for medical needs.
